PLXS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PLXS is not a good buy right now at 200.5. The setup is extended (RSI ~81) and price is sitting at/just above a key resistance zone (200.25) after a strong run, while insider selling has sharply increased. Despite a solid Q1 print and upbeat Q2 revenue guide, the risk/reward for an impatient entry is unfavorable at current levels; this is a HOLD (wait for a better entry/pullback rather than buying here).
Trend is bullish but stretched. Moving averages are strongly bullish (SMA_5 > SMA_20 > SMA_200) and MACD histogram is positive and expanding (1.465), confirming momentum. However, RSI_6 at 80.865 signals overbought conditions, increasing near-term pullback risk. Price is essentially at R2 (~200.25) and slightly above it (200.51), which often acts as short-term resistance; nearby levels: R1 ~193.87, pivot ~183.55. Pattern-based projection also leans slightly negative beyond the next day (-0.59% next week; -2.11% next month), suggesting limited upside from here.
Intellectia Proprietary Trading Signals
ahead of the print.
and price is pressing key resistance around ~200, raising pullback risk.
is still below the current price (~200.5), implying limited near-term upside vs that reference.
Latest quarter (FY2026/Q1): Revenue $1.0699B (+9.60% YoY), Net Income $41.18M (+10.51% YoY), EPS $1.51 (+12.69% YoY). Growth is solid across revenue/earnings, but profitability quality showed mild pressure as gross margin fell to 9.92% (-3.88% YoY). Management’s Q2 FY2026 revenue guidance ($1.11B–$1.15B) supports continued top-line momentum.
Recent trend: Benchmark maintained a Buy rating and raised its price target to $195 from $165 (2026-01-28), citing expectations for in-line results and a modestly better outlook. Wall Street pro view (from the provided data): Pros—consistent growth and improving outlook. Cons—current price is above the cited PT, suggesting the market may have already priced in much of the near-term good news, and margin softness/insider selling adds caution.
